Occam Places Padma Sundar as CBO at ChromaCode
ChromaCode, a private molecular diagnostics company with a bioinformatics focus, has added Padma Sundar as Chief Business Officer to lead commercialization. The company was founded by Illumina veteran Alex Dickinson and has NEA and Northpond as lead investors.
Padma brings deep knowledge of the cancer space and nearly two decades of rich accomplishment transforming diagnostic organizations with disruptive technologies into revenue stage companies with market leading tests. She most recently served as Chief Commercial Officer of Oncocyte, a precision diagnostics company.
Her career began in the healthcare practice of McKinsey &Co.
Padma earned both an MBA and an MPH from the University of California-Berkeley after completing her undergraduate degree in Chemistry at Delhi University.
View recent Placements
.jpg)
.jpg)
.jpg)
.jpg)
DISCOVER OCCAM GLOBAL
Occam Global is a leading executive search and advisory partner for entrepreneurs, investors, and corporations targeting exceptional goals across the life sciences, deep tech, and venture capital sectors worldwide. Since 2012, Occam has collaborated with top founders, CEOs, and investors across the tech industry to provide high-performing leaders who fuel growth. From stealth startups to public markets, we recruit senior executives, advise on organizational strategies, and invest alongside visionary teams to build innovative companies.
Occam’s success is rooted in our proven ability to attract outstanding business and scientific leaders, seamless access to rare talent, and a strong commitment to results guided by high ethics and enlightened aggression. Whether you’re launching, leading, or investing, we are here to support growth through the power of talent.